Tel: +86 (0)571 8102-5280 Email:
1045792-66-2 | CAY10603

CAY10603 NLT 98%

SKU : MC503954

CAS Number : 1045792-66-2

Molecular Formula : C22H30N4O6 | Molecular Weight : 446.50

Synonyms : BML-281

Quote Request
Purity NLT 98%
Storage at 20ºC 2 years

* The above information is for reference only.

* If the product has intellectual property rights, a license granted is must or contact us.

Chemical Name CAY10603
CAS Number 1045792-66-2
MDL Number MFCD17010286
Molecular Formula C22H30N4O6
Molecular Weight 446.50
Synonyms BML-281
Introduction of 1045792-66-2 :

CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM. IC50 & Target: IC50: 2 pM (HDAC6), 0.42 nM (HDAC3), 90.7 nM (HDAC10), 252 nM (HDAC2), 271 nM (HDAC1), 6851 nM (HDAC8)[1] In Vitro: CAY10603 (Compound 7) shows potent inhibitory activities against pancreatic cancer cell lines, with IC50s of 1, 0.3, 0.1, 0.1, 0.6, <1, 0.5 μM for BxPC-3, HupT3, Mia Paca-2, Panc 04.03, SU.86.86, HMEC, HPDE6c7, respectively. CAY10603 (100 nM, 200-300 nM) is active against both the Mia Paca-2 and Panc04.03 cell lines[1]. CAY10603 inhibits HDAC6 deacetylase activity, and supresses the proliferation of lung adenocarcinoma cells. CAY10603 also induces apoptosis of lung adenocarcinoma cells. Furthermore, CAY10603 synergizes with gefitinib to induce apoptosis in lung adenocarcinoma cell lines, partly through the destabilization of EGFR and inactivation of the EGFR pathway[2].

Related Products